1.
Cardiol Clin
; 29(4): 499-504, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22062197
RESUMO
Left ventricular assist device therapy as a destination therapy for end-stage heart failure has made a large leap with continuous flow devices. Continuous flow does not seem to have a detrimental effect on end-organ function, at least in the midterm. Various expected and unexpected complications have been reported associated with this technology. More experience and research are warranted.